Get started
Author

Sandya Arunachalam

ORCID: 0009-0007-1656-2349
Observed ORCID: 0009-0007-1656-2349
OpenAlex ID: A5017348495
Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa
2019 · Emmanuel J. Favaloro, Grace Gilmore, et al. · Thrombosis Research · 55
PDF
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays
2021 · Emmanuel J. Favaloro, Elysse Dean, et al. · Pathology · 40
PDF
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience
2022 · Emmanuel J. Favaloro, Elysse Dean, et al. · Seminars in Thrombosis and Hemostasis · 19
Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects
2020 · Emmanuel J. Favaloro, Grace Gilmore, et al. · Haemophilia · 17
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific Experience
2023 · Emmanuel J. Favaloro, Elysse Dean, et al. · Seminars in Thrombosis and Hemostasis · 13
Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference
2020 · Emmanuel J. Favaloro, Grace Gilmore, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 13
Continued harmonization of the international normalized ratio across a large laboratory network: Evidence of sustained low interlaboratory variation and bias after a change in instrumentation
2024 · Emmanuel J Favaloro, Sandya Arunachalam, et al. · American Journal of Clinical Pathology · 12
PDF
Variable Performance of D-dimer Testing by Hemostasis Laboratories: The Australasian/Asia-Pacific Experience
2024 · Emmanuel J. Favaloro, Sandya Arunachalam, et al. · Seminars in Thrombosis and Hemostasis · 10
Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific
2025 · Emmanuel J. Favaloro, Sandya Arunachalam, et al. · International Journal of Laboratory Hematology · 7
PDF
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers—for the External Quality Assurance in Thrombosis and Haemostasis Group
2024 · Ian Jennings, Piet Meijer, et al. · Seminars in Thrombosis and Hemostasis · 5
Performance of direct oral anticoagulant ( DOAC ) testing by hemostasis laboratories: The Australasian/ Asia‐Pacific experience
2024 · Emmanuel J. Favaloro, Sandya Arunachalam, et al. · International Journal of Laboratory Hematology · 5
PDF
External Quality Assessment for Unfractionated Heparin Monitoring: An Update from Australasia/Asia-Pacific
2025 · Emmanuel J. Favaloro, Sandya Arunachalam, et al. · Seminars in Thrombosis and Hemostasis · 3
Factor Inhibitor Testing: An Update from Australasia/Asia-Pacific
2025 · Emmanuel J. Favaloro, Sandya Arunachalam · Seminars in Thrombosis and Hemostasis · 2
External Quality Assessment for Low Molecular Weight Heparin Monitoring in the Australasia/Asia-Pacific Region
2026 · Emmanuel J. Favaloro, Sandya Arunachalam, et al. · Seminars in Thrombosis and Hemostasis · 1
Ongoing improvements in laboratory performance of coagulation factors VIII and IX: recent experience from the RCPAQAP
2020 · Sandya Arunachalam, Emmanuel J. Favaloro · Annals of Blood · 1
100 Years of von Willebrand Disease (VWD): Comparison of Historical and Contemporary von Willebrand Factor (VWF) Activity Assays in the Laboratory Identification of VWD
2026 · Emmanuel J. Favaloro, Sandya Arunachalam, et al. · Haemophilia
PDF
PB3472 Global Insights in PFA performance across the world by two EQA programmes
2026 · Sandya Arunachalam, Claudia van Rijn, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devices
2026 · Sandya Arunachalam, Tony Badrick, et al. · Clinical Chemistry and Laboratory Medicine (CCLM)
Different lens, same target: how molecular genetics, haematology, and external quality assurance converge to enhance diagnostic precision
2026 · Nalishia Munusamy, Elinor Cobbin, et al. · Pathology
Antiphospholipid syndrome: an external quality assurance integrated perspective
2026 · Sandya Arunachalam, Vraj Evans, et al. · Pathology
Unfractionated heparin monitoring with activated partial thromboplastin time – RCPAQAP questionnaire review
2019 · Sandya Arunachalam, Fernando Estepa, et al. · Pathology
Works count: 21
Citation count: 203
H-index: 8
I10-index: 8
Year
Topic
Type